banner
Ulex europaeus lectin I (UEA-I), Gorse (Furze), Alkaline phosphatase conjugate
Inquiry

Cat. No.: XLC-73-03Q

Ulex europaeus lectin I (UEA-I), Gorse (Furze), Alkaline phosphatase conjugate

Synonym: UEA-I; Gorse-furze-agglutinin

img
Product Size
1 mg
Price
Datasheet
MSDS
Properties
Description
Ulex europaeus lectin I (UEA-I) specially binds to α-Fucose. Inhibiting or Eluting Sugar: L-Fucose. This product can be used in glycobiology, immunochemistry, immunofluorescence, western blot and enzyme-linked immunosorbent assay.
Biological Source
Gorse (Furze)
Concentration
1 mg/mL
Conjugate
Alkaline phosphatase
Carbonhydrate Specificity
α-Fucose
Inhibiting or Eluting Sugar
L-Fucose
Blood Group Specificity
Non-specific
Divalent Ions
Ca++, Mn++, Zn++
Form
Liquid
Potency
UEA-I (< 4 µg/mL) agglutinates human type O erythrocytes; UEA-I (< 0.5 µg/mL) agglutinates neuraminidase treated erythrocytes.
Buffer
0.01 M PBS (pH 7.2)
Preservative
0.05% sodium azide
Applications
Glycobiology, Immunochemistry, Immunofluorescence, Western blot, Enzyme-linked immunosorbent assay
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0